Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer.

Banerjee S, Kaseb AO, Wang Z, Kong D, Mohammad M, Padhye S, Sarkar FH, Mohammad RM

DOI: 10.1158/0008-5472.can-08-4235
Published: 2009 Jul 1
Container: Cancer research
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/0008-5472.can-08-4235,
  title = {Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer.},
  author = {Banerjee S and Kaseb AO and Wang Z and Kong D and Mohammad M and Padhye S and Sarkar FH and Mohammad RM},
  year = {2009},
  journal = {Cancer research},
  doi = {10.1158/0008-5472.can-08-4235},
  url = {https://doi.org/10.1158/0008-5472.can-08-4235}
}

RIS

TY  - JOUR
TI  - Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer.
AU  - Banerjee S
AU  - Kaseb AO
AU  - Wang Z
AU  - Kong D
AU  - Mohammad M
AU  - Padhye S
AU  - Sarkar FH
AU  - Mohammad RM
PY  - 2009
JO  - Cancer research
DO  - 10.1158/0008-5472.can-08-4235
UR  - https://doi.org/10.1158/0008-5472.can-08-4235
ER  -

APA

S, B., AO, K., Z, W., D, K., M, M., S, P., FH, S., & RM, M. (2009). Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer.. Cancer research. https://doi.org/10.1158/0008-5472.can-08-4235

Source records

pubmed · retrieved 2026-11-10T14:45:46.247Z